Q2 2025 · 13F-HR
Whitefort Capital Management, LPholdings as filed
Filed 2025-08-14 · accession 0001013594-25-001036
$340.8M
Reported value
18
Positions
2025-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 78463V107 | GLD | SPDR GOLD TR | $82.3M | 24.1% | 270,000 | CALL | SOLE |
| 46591M109 | JOYY | JOYY INC | $46.6M | 13.7% | 914,943 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $43.8M | 12.8% | 3,882,000 | Common | SOLE |
| 03879J100 | ABUS | ARBUTUS BIOPHARMA CORP | $41.2M | 12.1% | 13,343,228 | Common | SOLE |
| 37247D106 | GNW | GENWORTH FINL INC | $25.1M | 7.35% | 3,221,960 | Common | SOLE |
| 68218J103 | OABI | OMNIAB INC | $17.8M | 5.23% | 10,240,146 | Common | SOLE |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $16.6M | 4.87% | 1,331,602 | Common | SOLE |
| 68375NAG8 | OPK 3.75 01/15/29 | OPKO HEALTH INC | $12.9M | 3.77% | 9,350,000 | Common | SOLE |
| 127537207 | CDZI | CADIZ INC | $11.9M | 3.50% | 3,986,822 | Common | SOLE |
| 36472T109 | TDAY | GANNETT CO INC | $9.6M | 2.81% | 2,671,921 | Common | SOLE |
| Y27183600 | GSL | GLOBAL SHIP LEASE INC NEW | $9.3M | 2.73% | 353,857 | Common | SOLE |
| 86881A100 | SGRY | SURGERY PARTNERS INC | $8.2M | 2.42% | 371,000 | Common | SOLE |
| 404139AG2 | VATE 7.5 08/01/26 * | INNOVATE CORP | $6.3M | 1.86% | 12,218,000 | Common | SOLE |
| 45784J303 | VATE | INNOVATE CORP | $3.8M | 1.12% | 743,000 | Common | SOLE |
| G5260K102 | KG | KESTREL GROUP LTD | $2.7M | 0.80% | 102,206 | Common | SOLE |
| 68375N103 | OPK | OPKO HEALTH INC | $2.3M | 0.69% | 1,774,200 | Common | SOLE |
| 65345N114 | NNAVW | NEXTNAV INC | $300,126 | 0.09% | 47,264 | Common | SOLE |
| 896438504 | TRIB | TRINITY BIOTECH PLC | $53,236 | 0.02% | 81,902 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.